Medicine Description trathesia 10mg
Trathesia is an advanced pharmaceutical preparation intended exclusively for use in hospitals and operating rooms. It
is classified as a skeletal muscle relaxant
(neuromuscular blocking agent) that works by blocking neuromuscular transmission, allowing complete relaxation of
voluntary muscles during surgical procedures.
The medication plays an essential role in facilitating general anesthesia and enabling endotracheal intubation for
mechanical ventilation in operating rooms, intensive care units, and emergency settings. It provides temporary and
controlled muscle relaxation, helping surgical procedures proceed safely and efficiently.
Trathesia Ingredients
Trathesia Strengths
Uses of Trathesia
Producing complete skeletal muscle relaxation during major surgical procedures.
Facilitating endotracheal intubation for general anesthesia or mechanical ventilation.
Assisting in controlled mechanical ventilation for patients in intensive care units.
Dosage of Trathesia
The dosage is determined by the anesthesiologist based on the patient's body weight, clinical condition, and the type
of surgical procedure. In adults, the usual initial dose ranges from 0.3 to 0.6 mg/kg administered intravenously to
achieve the desired degree of neuromuscular blockade.
Additional maintenance doses may be administered to sustain muscle relaxation throughout surgery. For patients
requiring prolonged mechanical ventilation in intensive care units, the medication may be given as a continuous
intravenous infusion.
The infusion rate and dosage should be adjusted according to the patient's clinical response under continuous
monitoring by qualified healthcare professionals.
Side Effects of Trathesia
Temporary flushing of the face or skin and mild transient hypotension.
Mild bronchospasm or airway constriction, particularly in patients with a history of asthma.
Temporary increase in heart rate that usually resolves shortly after administration.
Contraindications
This medication should not be used in patients with known hypersensitivity to atracurium besylate, cisatracurium, or
any component of the formulation.
It must only be administered under the direct supervision of trained anesthesia personnel in facilities equipped with
immediate respiratory support and mechanical ventilation equipment. Caution is also required in patients with severe
or unstable cardiovascular disorders unless the clinical situation makes its use essential.
Trathesia Alternatives
Atracurium Besylate
Atrabesylate
Faulcurium
How to Use Trathesia Correctly
Trathesia should be administered only by intravenous injection or continuous intravenous infusion after appropriate
dilution with compatible solutions. Administration must be performed by an anesthesiologist or qualified healthcare
professionals in a hospital setting.
During administration, the patient's vital signs, including blood pressure, heart rate, and respiratory function,
should be monitored continuously to ensure patient safety and allow prompt management of any adverse reactions.
The compatibility guidelines for intravenous administration should be strictly followed. The medication should not be
mixed with incompatible intravenous solutions or medications, including alkaline solutions such as thiopental, as
precipitation or chemical incompatibility may occur.
Storage Conditions
Store refrigerated at 2–8°C. Do not freeze.
Keep the ampoules in their original carton to protect them from light.
Store in a secure medication storage area out of the reach of children and unauthorized individuals.